Biotech R&D spending share selected countries by size 2014

This statistic shows the percentage of research and development spending of biotechnology companies based in OECD countries for 2014 (or latest year available), by firm size. In that year, small biotechnology companies in Austria spent 60.9 percent of the country's biotechnology research and development expenditures.

Percentage of biotech R&D expenditure in selected countries in 2014, by company size*

Characteristic	Small firms	Medium and large firms
Israel	67.1%	32.9%
Austria	60.9%	39.1%
Estonia	49.8%	50.2%
Portugal	41.3%	58.7%
Slovak Republic	39.3%	60.7%
Spain	38.3%	61.7%
Norway	35.9%	64.1%
Germany**	31.2%	68.8%
Finland	29.6%	70.4%
Czech Republic	25.6%	74.4%
Ireland	25.2%	74.8%
Sweden	18%	82%
Italy	16.4%	83.6%
France	15.6%	84.4%
South Africa	14.4%	85.6%
Poland	11.6%	88.4%
Korea	9.5%	90.5%
Switzerland	9.1%	90.9%
Denmark	8.9%	91.1%
Slovenia	8.6%	91.4%
Netherlands	7.9%	92.1%
United States	6.8%	93.2%
Belgium	5%	95%
Mexico	3.9%	96.1%

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

November 2017

More information

Region

OECD

Survey time period

2014

Supplementary notes

* Or latest year available.
** Figures from 2015.
For Denmark and France data are preliminary.
For Mexico, firms with 20 or more employees only. Economic units in biotechnology and nanotechnology have failed to maintain a strategy of long-term growth possibly among other things, due to the low linkage between industry and academia, and because the strategy of innovation in the productive sector is mainly the customer service department.
For the Netherlands and Sweden, firms with 10 or more employees only.
For the United States firms with 5 or more employees only. For the United States, beginning with 2013, changes in data collection and imputation processes affected the comparability of company count estimates with estimates published for prior years. At the time of this release, further research is underway to address the year-to-year volatility in company count estimates.
Israel "“The statistical data for Israel are supplied by and under the responsibility of the relevant Israeli authorities. The use of such data by the OECD is without prejudice to the status of the Golan Heights, East Jerusalem and Israeli settlements in the West Bank under the terms of international law.” “It should be noted that statistical data on Israeli patents and trademarks are supplied by the patent and trademark offices of the relevant countries.” "

Citation formats